image goes here
Institutional Perspectives: Leveraging Technology to Meet Operational Goals During COVID-19
The COVID-19 pandemic ushered in a myriad of changes for clinical research professionals. One of the most impactful has been the immediate shift to remote processes to accommodate both research staff and participants. Enterprise-level technology is vital to ensuring business continuity across the industry. As clinical research continues to evolve, these systems are going to be even more important to enable rapid study activation, efficient recruitment and enrollment, and participant-centric research.
Join presenters including Mark King, VP Research & Innovation at Novant Health, and Alison Lakin, Associate Vice Chancellor for Regulatory Compliance and Research Integrity Officer at the University of Colorado Denver Anschutz Medical Campus to hear institutional perspectives on leveraging technology to set your site up for success both now and in the post-COVID-19 clinical research landscape.
Learning Objectives:
- Identify how institutions use technology to help ensure efficient processes and compliance as they restart research
- Outline steps sites currently take to build a foundation to thrive in an increasingly remote research ecosystem
- Discover perspectives on how the industry will fundamentally change in the months and years ahead, and where you can drive return on your technology investment
Presented By
Mark J. King
VP Research & Innovation
Novant Health
Alison Lakin
Associate Vice Chancellor for Regulatory Compliance, and Research Integrity Officer
University of Colorado Denver, Anschutz Medical Campus
James Wurdeman
Chief Product Officer, Forte Products
Advarra
NA
NA
NA
NA
DATE: July 8, 2020
Time: 1 pm ET | 10 am PT
Duration: 1 hour